Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore various ways to grow wealth with low risk that can help you achieve financial security. Start making informed investment choices today.
27,305 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
Bitcoin starts May above $80,000, reclaiming a key moving average and signaling renewed upside. This report breaks do...
A speculative bid by GameStop to purchase eBay sparks fresh debate about stock-based deals and the risk of overpaying...
Bitcoin climbs as aggressive spot demand sweeps in, lifting BTC to multi-week highs while U.S. data tests trader nerv...
As the first-quarter report for Innovate lands, investors eye more than just the top line. This guide breaks down wha...
As of mid-May 2026, two retail ETFs diverge sharply: RTH climbs on mega-cap strength, while XRT drifts lower with a b...
Bitcoin faces a fresh test as sentiment cools despite a modest near-term upside. Markets monitor whether BTC can recl...
Hive Digital Technologies stock surged this week thanks to a major AI infrastructure project from its subsidiary. Thi...
This deep dive breaks down NextPlat's Q1 2026 earnings, translating the numbers into practical takeaways for investor...
Ethereum-focused ETFs faced a heavy outflow spell, totaling $708 million over 14 sessions, while XRP and Solana poste...
Strategy disclosed a record unrealized loss on its Bitcoin holdings, topping $10 billion as bitcoin trades near $61,0...